WHAT ARE THE OPTIONS FOR A PERSON WITH ATOPIC DERMATITIS/ECZEMA WHO COMES INTO CONTACT WITH VACCINIA?
With early recognition and appropriate use of Vaccinia Immune Globulin (VIG), mortality can be reduced to zero, and morbidity alleviated. However, even if there is a delay in recognition, prompt institution of VIG should be undertaken. Untreated patients become quite ill and evidence systemic symptoms. If unrecognized and untreated, the patient will manifest severe systemic symptoms resembling septic shock, and death ensues.
